Regeneron Pharmaceuticals said Monday it will acquire substantially all of DNA-testing outfit 23andMe for $256 million after coming out on top at a bankruptcy auction.
The post 23andMe Finds A Big Biotech Buyer In $256 Million Bankruptcy Auction appeared first on Investor’s Business Daily.
Regeneron Pharmaceuticals said Monday it will acquire substantially all of DNA-testing outfit 23andMe for $256 million after coming out on top at a bankruptcy auction.
The post 23andMe Finds A Big Biotech Buyer In $256 Million Bankruptcy Auction appeared first on Investor’s Business Daily.
Regeneron Pharmaceuticals said Monday it will acquire substantially all of DNA-testing outfit 23andMe for $256 million after coming out on top at a bankruptcy auction.
The post 23andMe Finds A Big Biotech Buyer In $256 Million Bankruptcy Auction appeared first on Investor’s Business Daily. Read MoreTechnology, All News And Stock Ideas, Biotech And Pharma Stock News Technology | Investor’s Business Daily
